ICR scientists study cancer response to new class of drugs by Fleur Jeffries | Oct 24, 2022 | News | 0 The research could help determine drug responses through genetic testing Read More
US approves first Herceptin biosimilar by Selina McKee | Dec 4, 2017 | News | 0 Mylan and Biocon’s Ogivri is the first biosimilar of Herceptin to win US approval, for certain breast cancer and metastatic stomach cancers. Read More